The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Moderna Inc shares valued at $40,539 were sold by Klinger Shannon Thyme on Sep 09 ’24. At $73.57 per share, Klinger Shannon Thyme sold 551 shares. The insider’s holdings dropped to 18,154 shares worth approximately $1.23 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Klinger Shannon Thyme purchased 551 shares, netting a total of over 40,539 in proceeds.
Before that, Klinger Shannon Thyme had sold 114 shares from its account. In a trade valued at $8,777, the Chief Legal Officer traded Moderna Inc shares for $76.99 each. Upon closing the transaction, the insider’s holdings decreased to 114 shares, worth approximately $1.19 million.
As published in a research note from Oppenheimer on September 13, 2024, Moderna Inc [MRNA] has been rated down from an Outperform to a Perform. Analysts at JP Morgan downgraded the stock from ‘”a Neutral”‘ to ‘”an Underweight”‘ outlook in a report released in mid September. As of September 13, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for MRNA. Earlier on August 28, 2024, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Reduce”.
Analyzing MRNA Stock Performance
During the last five days, there has been a drop of approximately -2.38%. Over the course of the year, Moderna Inc shares have dropped approximately -31.60%. Shares of the company reached a 52-week high of $170.47 on 05/24/24 and a 52-week low of $64.11 on 09/12/24. A 50-day SMA is recorded $92.10, while a 200-day SMA reached $105.98. Nevertheless, trading volume fell to 5.05 million shares from 7.18 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 66.63, which, if violated, would cause prices to drop to 65.24. In the upper region, resistance lies at 70.69. The next price resistance is at 73.36. RSI (Relative Strength Index) is 32.12 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.01, which suggests the price will decrease in the coming days. Percent R is at 75.33%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
